American Journal of Cardiology
Volume 102, Issue 6, Supplement , Pages 12H-19H, 22 September 2008

New Horizons in Antiarrhythmic Therapy: Will Novel Agents Overcome Current Deficits?

Division of Cardiovascular Diseases, Main Line Health Heart Center, Wynnewood, Pennsylvania, USA; and Jefferson Medical College, Philadelphia, Pennsylvania, USA

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Statement of author disclosure: Please see the Author Disclosures section at the end of this article.

PII: S0002-9149(08)01081-3

doi:10.1016/j.amjcard.2008.06.025

American Journal of Cardiology
Volume 102, Issue 6, Supplement , Pages 12H-19H, 22 September 2008